Research Recommends Vaccinating Everyone Against Flu

May 22, 2014 A €1.2 million European project says mass vaccinations are the most cost-effective way to deal with flu. This should be followed by targeted treatment of those displaying symptoms, not mass issuing of drugs like Tamiflu. The recommendations come from the world’s first extensive cost-effectiveness analysis flu responses. The Fluresp project has written to UK and European governments …

Tamiflu: a waste of £500 million?

Annual vaccination is the best strategy to prevent influenza. However, as the vaccine industry continues to work towards developing a Universal Flu Vaccine, it is important to consider the available treatment options and subsequently to make sure that the public is kept up-to-date with the options available to them. Last week, the UK media was alight with claims that the government …

Tamiflu Reduced Risk of Death by 25% in Patients Hospitalised with H1N1

A meta-analysis published online today in The Lancet Respiratory Medicine has concluded that patients admitted to hospital with H1N1 influenza during the 2009/2010 pandemic were 25% less likely to die from the disease if they had been given neuraminidase inhibitors (NAIs) such as Roche’s Tamilfu. Until now, [Governments] had no adequate data to assist them in deciding if lives were saved in 2009-2010 …